185 related articles for article (PubMed ID: 31683965)
1. Targeted Delivery Prodigiosin to Choriocarcinoma by Peptide-Guided Dendrigraft Poly-l-lysines Nanoparticles.
Zhao K; Li D; Cheng G; Zhang B; Han J; Chen J; Wang B; Li M; Xiao T; Zhang J; Zhou D; Jin Z; Fan X
Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31683965
[TBL] [Abstract][Full Text] [Related]
2. Targeting delivery of partial VAR2CSA peptide guided N-2-Hydroxypropyl trimethyl ammonium chloride chitosan nanoparticles for multiple cancer types.
Zhao K; Cheng G; Zhang B; Li D; Han J; Chen J; Wang B; Li M; Xiao T; Le A; Sun B; Jin Z; Zhang J; Fan X
Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110171. PubMed ID: 31753378
[TBL] [Abstract][Full Text] [Related]
3. Biological Potential and Mechanism of Prodigiosin from
Li D; Liu J; Wang X; Kong D; Du W; Li H; Hse CY; Shupe T; Zhou D; Zhao K
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400387
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Characterization of Placental Chondroitin Sulfate A (plCSA)-Targeting Lipid-Polymer Nanoparticles.
Zhang B; Zheng M; Cai L; Fan X
J Vis Exp; 2018 Sep; (139):. PubMed ID: 30295666
[TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of doxorubicin by CSA-binding nanoparticles for choriocarcinoma treatment.
Zhang B; Cheng G; Zheng M; Han J; Wang B; Li M; Chen J; Xiao T; Zhang J; Cai L; Li S; Fan X
Drug Deliv; 2018 Nov; 25(1):461-471. PubMed ID: 29426237
[TBL] [Abstract][Full Text] [Related]
6. Placenta-specific drug delivery by trophoblast-targeted nanoparticles in mice.
Zhang B; Tan L; Yu Y; Wang B; Chen Z; Han J; Li M; Chen J; Xiao T; Ambati BK; Cai L; Yang Q; Nayak NR; Zhang J; Fan X
Theranostics; 2018; 8(10):2765-2781. PubMed ID: 29774074
[No Abstract] [Full Text] [Related]
7. Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods.
Zhang B; Chen Z; Han J; Li M; Nayak NR; Fan X
J Vis Exp; 2018 Sep; (139):. PubMed ID: 30247484
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous dimer peptide-conjugated polylysine dendrimer-Fe
Shen JM; Li XX; Fan LL; Zhou X; Han JM; Jia MK; Wu LF; Zhang XX; Chen J
Int J Nanomedicine; 2017; 12():1183-1200. PubMed ID: 28243083
[TBL] [Abstract][Full Text] [Related]
9. A bacteria deriving peptide modified dendrigraft poly-l-lysines (DGL) self-assembling nanoplatform for targeted gene delivery.
Liu Y; He X; Kuang Y; An S; Wang C; Guo Y; Ma H; Lou J; Jiang C
Mol Pharm; 2014 Oct; 11(10):3330-41. PubMed ID: 24964270
[TBL] [Abstract][Full Text] [Related]
10. Extraction and encapsulation of prodigiosin in chitosan microspheres for targeted drug delivery.
Dozie-Nwachukwu SO; Danyuo Y; Obayemi JD; Odusanya OS; Malatesta K; Soboyejo WO
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():268-278. PubMed ID: 27987708
[TBL] [Abstract][Full Text] [Related]
11. Prodigiosin release from an implantable biomedical device: kinetics of localized cancer drug release.
Danyuo Y; Obayemi JD; Dozie-Nwachukwu S; Ani CJ; Odusanya OS; Oni Y; Anuku N; Malatesta K; Soboyejo WO
Mater Sci Eng C Mater Biol Appl; 2014 Sep; 42():734-45. PubMed ID: 25063175
[TBL] [Abstract][Full Text] [Related]
12. PLGA-based microparticles loaded with bacterial-synthesized prodigiosin for anticancer drug release: Effects of particle size on drug release kinetics and cell viability.
Obayemi JD; Danyuo Y; Dozie-Nwachukwu S; Odusanya OS; Anuku N; Malatesta K; Yu W; Uhrich KE; Soboyejo WO
Mater Sci Eng C Mater Biol Appl; 2016 Sep; 66():51-65. PubMed ID: 27207038
[TBL] [Abstract][Full Text] [Related]
13. Platinum-Based Nanovectors Engineered with Immuno-Modulating Adjuvant for Inhibiting Tumor growth and Promoting Immunity.
Liu L; Chen Q; Ruan C; Chen X; Zhang Y; He X; Zhang Y; Lu Y; Guo Q; Sun T; Wang H; Jiang C
Theranostics; 2018; 8(11):2974-2987. PubMed ID: 29896297
[TBL] [Abstract][Full Text] [Related]
14. Trophoblast-Targeted Liposomes for Placenta-Specific Drug Delivery.
Zhang B; Fan X; Nayak NR
Methods Mol Biol; 2024; 2728():173-180. PubMed ID: 38019401
[TBL] [Abstract][Full Text] [Related]
15. Biodegradable nanoparticles composed of dendrigraft poly-L-lysine for gene delivery.
Kodama Y; Nakamura T; Kurosaki T; Egashira K; Mine T; Nakagawa H; Muro T; Kitahara T; Higuchi N; Sasaki H
Eur J Pharm Biopharm; 2014 Aug; 87(3):472-9. PubMed ID: 24813391
[TBL] [Abstract][Full Text] [Related]
16. Tumor-Associated Fibroblast-Targeted Regulation and Deep Tumor Delivery of Chemotherapeutic Drugs with a Multifunctional Size-Switchable Nanoparticle.
Cun X; Chen J; Li M; He X; Tang X; Guo R; Deng M; Li M; Zhang Z; He Q
ACS Appl Mater Interfaces; 2019 Oct; 11(43):39545-39559. PubMed ID: 31617997
[TBL] [Abstract][Full Text] [Related]
17. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery.
Lee JY; Chung SJ; Cho HJ; Kim DD
Eur J Pharm Biopharm; 2015 Aug; 94():532-41. PubMed ID: 26149228
[TBL] [Abstract][Full Text] [Related]
18. Chondroitin Sulfate Targeting Nanodrug Achieves Near-Infrared Fluorescence-Guided Chemotherapy Against Triple-Negative Breast Primary and Lung Metastatic Cancer.
Huang C; Li C; Cai J; Chen J; Wang B; Li M; Zhou W; Wang J; Zhang P; Zhang JV
Int J Nanomedicine; 2022; 17():5547-5563. PubMed ID: 36444194
[TBL] [Abstract][Full Text] [Related]
19. Polyethylene glycol-conjugated chondroitin sulfate A derivative nanoparticles for tumor-targeted delivery of anticancer drugs.
Lee JY; Park JH; Lee JJ; Lee SY; Chung SJ; Cho HJ; Kim DD
Carbohydr Polym; 2016 Oct; 151():68-77. PubMed ID: 27474544
[TBL] [Abstract][Full Text] [Related]
20. Peptide mediated active targeting and intelligent particle size reduction-mediated enhanced penetrating of fabricated nanoparticles for triple-negative breast cancer treatment.
Hu G; Chun X; Wang Y; He Q; Gao H
Oncotarget; 2015 Dec; 6(38):41258-74. PubMed ID: 26517810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
